![]() | Review waiting, please be patient.
This may take 4 months or more, since drafts are reviewed in no specific order. There are 2,725 pending submissions waiting for review.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Reviewer tools
|
Submission declined on 25 July 2024 by
S0091 (
talk). This submission does not appear to be written in
the formal tone expected of an encyclopedia article. Entries should be written from a
neutral point of view, and should refer to a range of
independent, reliable, published sources. Please rewrite your submission in a more encyclopedic format. Please make sure to avoid
peacock terms that promote the subject.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
This draft has been resubmitted and is currently awaiting re-review. | ![]() |
Enrique de-Madaria (born October 20, 1975, in Alicante, Spain), is a gastroenterologist and researcher specializing in pancreatic and biliary diseases. [1] His primary research focus is acute pancreatitis, particularly early-phase fluid therapy. He is also the founder of the "Race of the Cities Against Pancreatic Cancer," an international sporting event that has raised over a million euros for pancreatic cancer research. [2]
Enrique de-Madaria (Enrique de Madaria Pascual) was born in Alicante, Spain, in 1975. He studied medicine at the Miguel Hernández University of Elche and completed his residency in gastroenterology at the Hospital General Universitario de Alicante (currently known as Hospital General Universitario Dr. Balmis). He is in charge of the Biliopancreatic Unit at the Hospital General Universitario Dr. Balmis and is an associate professor at Miguel Hernandez University.
Since the late 1990s, aggressive intravenous fluid therapy was recommended for patients with acute pancreatitis, with the belief that resultant hemodilution would ensure adequate blood flow to the pancreas, preventing glandular necrosis and improving prognosis. [3] In 2011, Enrique de-Madaria published a prospective observational study indicating that patients receiving aggressive fluid therapy had a worse disease course. [4] In 2018, he conducted a single-center randomized clinical trial demonstrating that lactated Ringer's solution had anti-inflammatory properties in acute pancreatitis. [5] In 2022, he published the results of the WATERFALL randomized controlled trial in the New England Journal of Medicine. [6] This study compared aggressive versus moderate fluid therapy in 249 patients across 18 centers in four countries, showing that aggressive fluid therapy was unsafe and associated with a threefold increase in cardiopulmonary overload events. The findings influenced the 2024 American College of Gastroenterology guidelines to recommend moderate fluid therapy for acute pancreatitis based on this research. [7] Additionally, Enrique de-Madaria and his collaborators developed the PAN-PROMISE, a Patient Reported Outcome Measurement tool that assesses the main symptoms of acute pancreatitis. This scale was validated in an international study and is a useful tool for exploring the subjective experiences of patients with acute pancreatitis. [8]
Enrique de-Madaria founded and served as the first president of the Spanish Pancreatology Association (AESPANC) from 2013 to 2016. He was also president of the Spanish Association of Gastroenterology from 2020 to 2023. [9]
In January 2015, Enrique de-Madaria organized a charity run between the towns of Mutxamel and Sant Joan in Alicante, on behalf of the Spanish Association of Pancreatology (AESPANC), to raise awareness about the high mortality rate of pancreatic cancer and to fund research. [10] That same year, additional events took place in Alicante and Las Rozas, Madrid, in collaboration with the patient association ACANPAN. Since 2015, the event has expanded to 14 cities in Spain, attracting over 60,000 participants and raising more than one million euros for pancreatic cancer research. [2]
Miguel Pérez Mateo Research Award in Gastroenterology (2016) [11] United European Gastroenterology (UEG) Rising Star Award (2017) [12] [13] TopDoctors Top 50 Best Doctors in Spain (2023) [14] United European Gastroenterology (UEG) Research Prize (2024) [15]
{{
cite journal}}
: Missing |author4=
(
help)
![]() | Review waiting, please be patient.
This may take 4 months or more, since drafts are reviewed in no specific order. There are 2,725 pending submissions waiting for review.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
Reviewer tools
|
Submission declined on 25 July 2024 by
S0091 (
talk). This submission does not appear to be written in
the formal tone expected of an encyclopedia article. Entries should be written from a
neutral point of view, and should refer to a range of
independent, reliable, published sources. Please rewrite your submission in a more encyclopedic format. Please make sure to avoid
peacock terms that promote the subject.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
This draft has been resubmitted and is currently awaiting re-review. | ![]() |
Enrique de-Madaria (born October 20, 1975, in Alicante, Spain), is a gastroenterologist and researcher specializing in pancreatic and biliary diseases. [1] His primary research focus is acute pancreatitis, particularly early-phase fluid therapy. He is also the founder of the "Race of the Cities Against Pancreatic Cancer," an international sporting event that has raised over a million euros for pancreatic cancer research. [2]
Enrique de-Madaria (Enrique de Madaria Pascual) was born in Alicante, Spain, in 1975. He studied medicine at the Miguel Hernández University of Elche and completed his residency in gastroenterology at the Hospital General Universitario de Alicante (currently known as Hospital General Universitario Dr. Balmis). He is in charge of the Biliopancreatic Unit at the Hospital General Universitario Dr. Balmis and is an associate professor at Miguel Hernandez University.
Since the late 1990s, aggressive intravenous fluid therapy was recommended for patients with acute pancreatitis, with the belief that resultant hemodilution would ensure adequate blood flow to the pancreas, preventing glandular necrosis and improving prognosis. [3] In 2011, Enrique de-Madaria published a prospective observational study indicating that patients receiving aggressive fluid therapy had a worse disease course. [4] In 2018, he conducted a single-center randomized clinical trial demonstrating that lactated Ringer's solution had anti-inflammatory properties in acute pancreatitis. [5] In 2022, he published the results of the WATERFALL randomized controlled trial in the New England Journal of Medicine. [6] This study compared aggressive versus moderate fluid therapy in 249 patients across 18 centers in four countries, showing that aggressive fluid therapy was unsafe and associated with a threefold increase in cardiopulmonary overload events. The findings influenced the 2024 American College of Gastroenterology guidelines to recommend moderate fluid therapy for acute pancreatitis based on this research. [7] Additionally, Enrique de-Madaria and his collaborators developed the PAN-PROMISE, a Patient Reported Outcome Measurement tool that assesses the main symptoms of acute pancreatitis. This scale was validated in an international study and is a useful tool for exploring the subjective experiences of patients with acute pancreatitis. [8]
Enrique de-Madaria founded and served as the first president of the Spanish Pancreatology Association (AESPANC) from 2013 to 2016. He was also president of the Spanish Association of Gastroenterology from 2020 to 2023. [9]
In January 2015, Enrique de-Madaria organized a charity run between the towns of Mutxamel and Sant Joan in Alicante, on behalf of the Spanish Association of Pancreatology (AESPANC), to raise awareness about the high mortality rate of pancreatic cancer and to fund research. [10] That same year, additional events took place in Alicante and Las Rozas, Madrid, in collaboration with the patient association ACANPAN. Since 2015, the event has expanded to 14 cities in Spain, attracting over 60,000 participants and raising more than one million euros for pancreatic cancer research. [2]
Miguel Pérez Mateo Research Award in Gastroenterology (2016) [11] United European Gastroenterology (UEG) Rising Star Award (2017) [12] [13] TopDoctors Top 50 Best Doctors in Spain (2023) [14] United European Gastroenterology (UEG) Research Prize (2024) [15]
{{
cite journal}}
: Missing |author4=
(
help)